Tryvio
(Aprocitentan)Small molecule
Idorsia Pharmaceuticals Ltd.Aprocitentan is a blood pressure medication that works by relaxing blood vessels, making it easier for the heart to pump blood throughout the body. It helps prevent serious complications from high blood pressure, such as heart disease, stroke, and kidney damage.[1]
0
Indications
11
Total Trials
0
Active Trials
0
Competitors
1
FDA Application
NDA/BLA/ANDA regulatory filings
6
Patents
Clinical
Trials by Indication[1]
Interaction1 trial
Statin1 trial
Midazolam1 trial
5 more indications
Essential Hypertension1 trial
Women1 trial
Hypertension1 trial
Chronic Kidney Disease1 trial
Regulatory
FDA Approval Timeline[3]
Mar 19, 2024
TRYVIO
NDA NDA217686
Sources
References
- [1]
- [2]
- [3]
- [4]FDA Orange Book — Patent and exclusivity data for Tryvio. U.S. Food & Drug Administration.
- [5]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Company